ENOV

Enovis Corp

ENOV, USA

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

https://www.enovis.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
ENOV
stock
ENOV

Reassessing Enovis (ENOV) Valuation After Principal Accounting Officer’s Largest-Ever Open Market Share Purchase Yahoo Finance

Read more →
ENOV
stock
ENOV

Enovis Amends Credit Agreement for Financial Flexibility TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$48.1111

Analyst Picks

Strong Buy

7

Buy

3

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.79

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-28.27 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-12.88 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

5.30 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.19

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 124.78% of the total shares of Enovis Corp

1.

BlackRock Inc

(15.6168%)

since

2025/06/30

2.

Vanguard Group Inc

(11.1945%)

since

2025/06/30

3.

American Century Companies Inc

(8.2879%)

since

2025/06/30

4.

iShares Core S&P Small-Cap ETF

(5.9561%)

since

2025/08/31

5.

American Century U.S. Small Cap Value

(5.3534%)

since

2025/06/30

6.

American Century Small Cap Value Inv

(5.3534%)

since

2025/06/30

7.

Dimensional Fund Advisors, Inc.

(5.1091%)

since

2025/06/30

8.

Davenport & Company LLC

(4.974%)

since

2025/06/30

9.

Dorsey Asset Management, LLC

(4.4667%)

since

2025/06/30

10.

State Street Corp

(4.3514%)

since

2025/06/30

11.

Royce & Associates, LP

(4.2319%)

since

2025/06/30

12.

Vanguard Total Stock Mkt Idx Inv

(3.1057%)

since

2025/07/31

13.

Hood River Capital Management LLC

(3.0363%)

since

2025/06/30

14.

River Road Asset Management, LLC

(2.5191%)

since

2025/06/30

15.

Vanguard Small Cap Index

(2.4323%)

since

2025/07/31

16.

Boston Partners Global Investors, Inc

(2.419%)

since

2025/06/30

17.

iShares Russell 2000 ETF

(2.4016%)

since

2025/08/31

18.

Morgan Stanley - Brokerage Accounts

(2.3701%)

since

2025/06/30

19.

Bank of America Corp

(2.3578%)

since

2025/06/30

20.

Geode Capital Management, LLC

(2.3486%)

since

2025/06/30

21.

Davenport Small Cap Focus

(1.9938%)

since

2025/07/31

22.

Paradigm Capital Management, Inc.

(1.9477%)

since

2025/06/30

23.

Hood River Small-Cap Growth Instl

(1.6654%)

since

2025/06/30

24.

Citadel Advisors Llc

(1.633%)

since

2025/06/30

25.

UBS Group AG

(1.6287%)

since

2025/06/30

26.

Vanguard Small Cap Value Index Inv

(1.5667%)

since

2025/07/31

27.

Charles Schwab Investment Management Inc

(1.5271%)

since

2025/06/30

28.

Royal Bank of Canada

(1.4916%)

since

2025/06/30

29.

Allspring Global Investments Holdings, LLC

(1.4184%)

since

2025/06/30

30.

Davenport Equity Opportunities

(1.3616%)

since

2025/07/31

31.

Royce Small-Cap Premier Quality

(1.3276%)

since

2025/06/30

32.

Royce Premier Invmt

(1.3276%)

since

2025/06/30

33.

DFA US Small Cap Value I

(1.2551%)

since

2025/07/31

34.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0688%)

since

2025/07/31

35.

American Cent US Sm Cap Val Eq Tr CL R2

(1.0681%)

since

2025/08/31

36.

Fidelity Small Cap Index

(1.0002%)

since

2025/06/30

37.

iShares S&P Small-Cap 600 Value ETF

(0.9296%)

since

2025/08/31

38.

BlackRock Global Equity Mkt Netrl Instl

(0.9168%)

since

2025/07/31

40.

iShares Russell 2000 Value ETF

(0.8807%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.8592

Latest Release

Date

2025-09-30

EPS Actual

0.75

EPS Estimate

0.65

EPS Difference

0.1

Surprise Percent

15.3846%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(3.5)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.